Associate Professor of Psychiatry Western Psychiatric Institute and Clinic University of Pittsburgh School of Medicine Email: fagiolinia@upmc.edu Phone: 412-246-5588 Fax: 412-246-5520 Assistant: Theresa Pagano, 412-246-5588, paganotl@upmc.edu Research Program Dr. Andrea Fagiolini specializes in the pharmacological treatment and in the conduct of treatment research protocols of mood and anxiety disorders. He is conducting research on the pharmacological treatment of mood and anxiety disorders, the prevention and treatment of medical comorbidities in individuals with bipolar disorders, and the importance of comorbid sub-threshold psychiatric symptoms for the outcome of the primary psychiatric disorders.

.

Leadership Positions and Honors Dr Fagiolini currently serves as the Medical Director of the Bipolar Disorder Center for Pennsylvanians and of the Depression and Manic Depression Prevention Program. Representative Publications  Fagiolini A, Buysse DJ, Frank E, Houck PR, Luther JF, Kupfer DJ: Tolerability of a combined treatment with lithium and paroxetine in bipolar depressed patients.  J Clin Psychopharmacol 21:474-478, 2001. Fagiolini A, Frank E, Houck PR, Mallinger AG, Swartz HA, Buysse DJ, Ombao H, Kupfer DJ: Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 63:528-533, 2002. Fagiolini A, Kupfer DJ, Houck PR, Novick D, Frank E:  Obesity as a correlate of outcome in patients with bipolar I disorder.  Am J Psychiatry 160:112-117, 2003. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disorders 7: 424-430, 2005

Revised 7/25/2006  la/tc